- Bedoelde u
- clinical materials, phase i as topics
Zoekresultaten - 6 results
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
n-Plasma is a multicentre nation-wide, randomized, open-label, phase II proof-of-concept clinical trial, evaluating the clinical efficacy and safety of the addition of convalescent plasma to the standard of ...
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).
issues in drug development, as illustrated by high rates of late-stage attritions in clinical development and postmarketing commitments required by regulatory institutions. In an effort to shift the ...
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
METHODS: We did a randomised, double-blind, placebo-controlled, phase 2 trial of MVA85A in adults infected with HIV-1, at two clinical sites, in Cape Town, South Africa and Dakar, Senegal. Eligible ...
An update on vaccines for tuberculosis- there is more to it than just waning of BCG efficacy with time.
Trials, Phase I as Topic Clinical Trials, Phase II as Topic Humans Tuberculosis Tuberculosis Vaccines Abstract: INTRODUCTION: Apart from better diagnostics and new anti-microbial drugs, an effective vaccine ...
How to evaluate emerging technologies in cervical cancer screening?
(2009) Keywords: Clinical Trials as Topic Diagnostic Tests, Routine Female Humans Mass Screening Uterine Cervical Neoplasms Abstract: Excellent recommendations exist for studying therapeutic and diagnostic ...
Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Female Humans Male Papillomavirus Infections Papillomavirus Vaccines Practice Guidelines as Topic Uterine Cervical Neoplasms Abstract: ...